2 mg nicotine gum + 4 mg nicotine gum
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Dental Pellicle
Conditions
Dental Pellicle
Trial Timeline
Jul 1, 2005 → Sep 1, 2005
NCT ID
NCT00174499About 2 mg nicotine gum + 4 mg nicotine gum
2 mg nicotine gum + 4 mg nicotine gum is a approved stage product being developed by Johnson & Johnson for Dental Pellicle. The current trial status is completed. This product is registered under clinical trial identifier NCT00174499. Target conditions include Dental Pellicle.
What happened to similar drugs?
0 of 7 similar drugs in Dental Pellicle were approved
Approved (0) Terminated (0) Active (7)
🔄Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tabletJohnson & JohnsonPhase 3
🔄Test acetaminophen + Commercial acetaminophen + Commercial ibuprofen + PlaceboJohnson & JohnsonPhase 3
🔄acetaminophen Tablet + acetaminophen Caplet + ibuprofen Liquid-filled capsule + Placebo Tablet + Placebo Caplet + Placebo Liquid-filled capsuleJohnson & JohnsonPhase 3
🔄Diclofenac potassium + Ibuprofen + Placebo to ibuprofen + Placebo to diclofenac potassiumNovartisPhase 3
🔄Naproxen sodium and caffeine (BAY2880376) + Naproxen sodium (Aleve) + Caffeine + PlaceboBayerPhase 3
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00174499 | Approved | Completed |
Competing Products
20 competing products in Dental Pellicle